One-time procedure for atrial fibrillation plus stroke prevention
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests doing a single procedure that treats atrial fibrillation (irregular heartbeat) and also reduces the risk of stroke by sealing off a small part of the heart. This might help people who need both treatments, so they can have one procedure instead of two.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have atrial fibrillation (irregular heartbeat)
- Your doctor has said you need a procedure to fix your irregular heartbeat (pulmonary vein isolation, or PVI)
- You are at higher risk for stroke, so your doctor would normally recommend a blood thinner (based on your CHA2DS2VA score)
- You are not pregnant and have not had a previous catheter ablation for atrial fibrillation (a prior procedure to treat the irregular heartbeat)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing if a procedure that combines two treatments—pulmonary vein isolation for atrial fibrillation and left atrial appendage closure to lower stroke risk—can be done safely together. It's for people who need both treatments.
This trial tests a procedure that closes off a small pouch in the heart (left atrial appendage) while also treating irregular heartbeat (atrial fibrillation) with a catheter ablation procedure. The goal is to reduce your stroke risk and treat your symptoms without needing blood thinners long-term.
This study tests whether combining a heart procedure (catheter ablation) with a device to close the left atrial appendage (LAAO) is safer or better than blood thinners alone for frail patients 75 years or older with atrial fibrillation and high stroke risk. It aims to find a treatment that reduces stroke while lowering bleeding risks.
This study tests a new approach for people with atrial fibrillation (a type of irregular heartbeat) who are also at high risk for stroke. It combines a procedure to fix the heart's electrical signals with closing off a small pouch in the heart to reduce stroke risk, potentially avoiding long-term blood thinners.
This trial compares two catheter ablation techniques for people with persistent atrial fibrillation (a type of irregular heartbeat that doesn't go away on its own). It will test whether a more extensive ablation (burning more heart tissue) works better than the standard procedure of isolating the pulmonary veins (the veins that bring blood from the lungs to the heart). If you have this condition and have had at least one episode in the past year, this study might help you find a more effective treatment.
This trial compares a procedure that blocks a heart blood-choke point (the left atrial appendage) versus taking blood thinners by mouth. It is for people with atrial fibrillation who have had a brain bleed and may be safer avoiding long-term blood thinners.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.